Epmedin C (Standard)

Overview

Epmedin C (Standard) is the analytical standard of Epmedin C. This product is intended for research and analytical applications. Epmedin C (Epimedin-C; Baohuoside-VI) is an orally active anti-inflammatory agent and immunomodulator that binds to multiple key proteins including UCP1, Caspase-1 , CDK2 and Keap1 . Epmedin C inhibits epithelial cell proliferation by disrupting the complex function of CDK2 / Cyclin E . Epmedin C also upregulates Nrf2 expression, reduces ROS levels and inhibits pro-inflammatory cytokine secretion, thereby effectively restoring antibody production and alleviating tissue damage. Epmedin C has good safety with no hepatotoxicity or skin sensitization, and it has been used in studies on diseases such as obesity, Deoxynivalenol ( HY-N6684 )-induced immunotoxicity and mammary hyperplasia.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Keap1-Nrf2 | Products > Signaling Pathways > CDK | Products > Signaling Pathways > Caspase

Product Information

• Catalog No.: HY-N0260R
• CAS No.: 110642-44-9
• Molecular Formula: C₃₉H₅₀O₁₉
• Molecular Weight: 822.80
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source